Minn. Ends Claims Against Novo Nordisk After It Agrees To Cap Insulin Costs At $35

( April 1, 2025, 2:52 PM EDT) -- NEWARK, N.J. — Minnesota on March 31 moved to dismiss, with prejudice, all of its claims against Novo Nordisk Inc. after a drugmaker signed a settlement agreement, release and order and agreed to make its insulin XE "insulin"  products available to consumers in Minnesota for no more than $35 for a monthly prescription....

Attached Documents

Related Sections